Where others have failed will Atl1102 succeed ?, page-271

@ The Zig and Gan Gans..

CR is immenient . Not many here want to hear that. I think if Non dilutive funding was coming , it would be here now. This was first mentioned last November and just by going at practical time, we are 10 months into this announcement. Sufficient time to do DD..as trial design is almost certain from the last feedback. Hence the costs should be known and that has been mentioned at $30 m in these reports..

Now really nothing wrong with CR.Its for a massive trial..If someone is offering you Non dilutive funding of $30m and expecting you to give away 20% of Europe, its ridiculous and hence we are better off to do a CR..But again ..not many here are happy to hear that..

Why do you think the SP has been dragged sideways...MY OPINION is CR..

Morgans and Wilsons are not paying 40c / share for their client...lets be honest. Also plenty of companies raising lately and all have done really well after the raise..Some SP has almost doubled or even more in every sector...

Any other funding would be a big surprise for me...TBH

Also raising $30-$40 m would oput ANP in a very strong position with $100 m MC....possibly $40 after raise with EV of $60m...Which is really cheap for a company planning 2b trials in Europe.

If anyone is expecting funding Sept might be the month for it...

Lets see..All IMO AND MY THOUGHTS..